Ischemic Stroke and Bilateral Pulmonary Embolism in COVID-19: COVID-Associated Coagulopathy or Heparin-Induced Thrombocytopenia

A main feature of coronavirus disease 2019 (COVID-19) pathogenesis is the high frequency of thrombosis, predominantly pulmonary embolism (PE). Anticoagulation therapy is a crucial part of the management. Heparin use for anticoagulation could increase the risk of heparin-induced thrombocytopenia (HIT...

Descripción completa

Detalles Bibliográficos
Autores principales: Soliman, Sara, Ghaly, Medhat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929198/
https://www.ncbi.nlm.nih.gov/pubmed/35356633
http://dx.doi.org/10.14740/jh956

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929198/
https://www.ncbi.nlm.nih.gov/pubmed/35356633
http://dx.doi.org/10.14740/jh956

Ejemplares similares